Skip to search formSkip to main contentSkip to account menu

procathepsin D

Known as: pro-cathepsin D 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
The aim of this study was to identify novel biomarkers for the diagnosis of, and potential therapeutic targets for… 
Review
2012
Review
2012
Procathepsin D (pCD) is overexpressed and secreted by cells of various tumor types including breast and lung carcinomas… 
2011
2011
Enzymatically inactive procathepsin D (pCD) has been established as an important factor in the development of lung cancer. In… 
Review
2009
Review
2009
Over the past decades, the paradigm that lysosomal enzymes participate only in non-specific protein degradation during cell death… 
Highly Cited
2008
Highly Cited
2008
Expression and secretion of procathepsin D (pCD) increases proliferation, metastasis and progression of breast cancer but the… 
2007
2007
Elevated level of procathepsin D (pCD), a zymogen of lysosomal aspartic proteinase cathepsin D, is associated with highly… 
2007
2007
Procathepsin D (pCD), a zymogen of lysosomal aspartic peptidase cathepsin D, overexpression is correlated with highly invasive… 
2007
2007
Procathepsin D (pCD) is a major secreted protein in estrogen receptor-positive (ER+) breast cancer cell lines. Several… 
2006
2006
BACKGROUND Procathepsin D (pCD) secreted by cancer cells, increases proliferation, metastasis and progression of breast cancer… 
1997
1997
The kinetics of transport and the processing of procathepsin D (proCD), the precursor of a lysosomal aspartyl protease involved…